Previous Article | Next Article 
Journal of Virology, October 2000, p. 9727-9731, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Human Immunodeficiency Virus Type 1 Vpr Protein Is
Incorporated into the Virion in Significantly Smaller Amounts than Gag
and Is Phosphorylated in Infected Cells
Barbara
Müller,1,*
Uwe
Tessmer,1
Ulrich
Schubert,1,2 and
Hans-Georg
Kräusslich1,
Heinrich-Pette-Institut, D-20251 Hamburg,
Germany,1 and Laboratory of Viral
Diseases, National Institute of Allergy and Infectious Diseases,
Bethesda, Maryland 0892-04602
Received 7 March 2000/Accepted 18 April 2000
Viral protein R (Vpr) of human immunodeficiency virus type 1 (HIV-1) is a small accessory protein involved in the nuclear import of
viral DNA and the growth arrest of host cells. Several studies have
demonstrated that a significant amount of Vpr is incorporated into the
virus particle via interaction with the p6 domain of Gag, and it is
generally assumed that Vpr is packaged in equimolar ratio to Gag. We
have quantitated the relative amount of Vpr in purified virions
following [35S]cysteine labeling of infected MT-4 cells,
as well as by quantitative immunoblotting and found that Vpr is present
in a molar ratio of approximately 1:7 compared to capsid. Analysis of
isolated core particles showed that Vpr is associated with the mature
viral core, despite quantitative loss of p6 from core preparations. Metabolic labeling of infected cells with
ortho[32P]phosphate revealed that a small fraction of Vpr
is phosphorylated in virions and infected cells.
*
Corresponding author. Present address: Abteilung
Virologie, Universität Heidelberg, Im Neuenheimer Feld 324, D-69120 Heidelberg, Germany. Phone: 49-6221-565002. Fax:
49-6221-565003. E-mail:Barbara_Mueller{at}med.uni-heidelberg.de.

Present address: Abteilung Virologie, Universität Heidelberg,
D-69120 Heidelberg,
Germany.
Journal of Virology, October 2000, p. 9727-9731, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Langevin, C., Maidou-Peindara, P., Aas, P. A., Jacquot, G., Otterlei, M., Slupphaug, G., Benichou, S.
(2009). Human Immunodeficiency Virus Type 1 Vpr Modulates Cellular Expression of UNG2 via a Negative Transcriptional Effect. J. Virol.
83: 10256-10263
[Abstract]
[Full Text]
-
Romani, B., Engelbrecht, S.
(2009). Human immunodeficiency virus type 1 Vpr: functions and molecular interactions. J. Gen. Virol.
90: 1795-1805
[Abstract]
[Full Text]
-
Laguette, N., Benichou, S., Basmaciogullari, S.
(2009). Human Immunodeficiency Virus Type 1 Nef Incorporation into Virions Does Not Increase Infectivity. J. Virol.
83: 1093-1104
[Abstract]
[Full Text]
-
Votteler, J., Studtrucker, N., Sorgel, S., Munch, J., Rucker, E., Kirchhoff, F., Schick, B., Henklein, P., Fossen, T., Bruns, K., Sharma, A., Wray, V., Schubert, U.
(2007). Proline 35 of Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Regulates the Integrity of the N-Terminal Helix and the Incorporation of Vpr into Virus Particles and Supports the Replication of R5-Tropic HIV-1 in Human Lymphoid Tissue Ex Vivo. J. Virol.
81: 9572-9576
[Abstract]
[Full Text]
-
Keppler, O. T., Allespach, I., Schuller, L., Fenard, D., Greene, W. C., Fackler, O. T.
(2005). Rodent Cells Support Key Functions of the Human Immunodeficiency Virus Type 1 Pathogenicity Factor Nef. J. Virol.
79: 1655-1665
[Abstract]
[Full Text]
-
Bruns, K., Fossen, T., Wray, V., Henklein, P., Tessmer, U., Schubert, U.
(2003). Structural Characterization of the HIV-1 Vpr N Terminus: EVIDENCE OF cis/trans-PROLINE ISOMERISM. J. Biol. Chem.
278: 43188-43201
[Abstract]
[Full Text]
-
Sherman, M. P., de Noronha, C. M. C., Eckstein, L. A., Hataye, J., Mundt, P., Williams, S. A. F., Neidleman, J. A., Goldsmith, M. A., Greene, W. C.
(2003). Nuclear Export of Vpr Is Required for Efficient Replication of Human Immunodeficiency Virus Type 1 in Tissue Macrophages. J. Virol.
77: 7582-7589
[Abstract]
[Full Text]
-
McDonald, D., Vodicka, M. A., Lucero, G., Svitkina, T. M., Borisy, G. G., Emerman, M., Hope, T. J.
(2002). Visualization of the intracellular behavior of HIV in living cells. JCB
159: 441-452
[Abstract]
[Full Text]
-
Muller, B., Patschinsky, T., Krausslich, H.-G.
(2002). The Late-Domain-Containing Protein p6 Is the Predominant Phosphoprotein of Human Immunodeficiency Virus Type 1 Particles. J. Virol.
76: 1015-1024
[Abstract]
[Full Text]
-
Jenkins, Y., Pornillos, O., Rich, R. L., Myszka, D. G., Sundquist, W. I., Malim, M. H.
(2001). Biochemical Analyses of the Interactions between Human Immunodeficiency Virus Type 1 Vpr and p6Gag. J. Virol.
75: 10537-10542
[Abstract]
[Full Text]
-
Jenkins, Y., Sanchez, P. V., Meyer, B. E., Malim, M. H.
(2001). Nuclear Export of Human Immunodeficiency Virus Type 1 Vpr Is Not Required for Virion Packaging. J. Virol.
75: 8348-8352
[Abstract]
[Full Text]
-
Sova, P., Volsky, D. J., Wang, L., Chao, W.
(2001). Vif Is Largely Absent from Human Immunodeficiency Virus Type 1 Mature Virions and Associates Mainly with Viral Particles Containing Unprocessed Gag. J. Virol.
75: 5504-5517
[Abstract]
[Full Text]